Buy or sell Caresyntax stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Caresyntax Stock

Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.

Founded

2013

Notable Investors

Whiz Partners

Headquarters

Boston MA, US

Total Funding

$208M

About Caresyntax Stock

Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.

Investors

Funding History

September 2017$11.9M
June 2018$20.0M
December 2019$45.6M
September 2021$130M

Management

Co-Founder and CEO

Dennis Kogan

Chief Financial Officer

Claire Masterson

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo